Anaptysbio (ANAB) Current Leases (2020 - 2026)

Anaptysbio's Current Leases history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• Quarterly Current Leases rose 8.05% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 8.05% YoY) and the FY2025 annual result came in at $2.1 million, up 8.05% from the prior year.
• Current Leases was $2.1 million for Q1 2026 at Anaptysbio, up from $2.1 million in the prior quarter.
• Across five years, Current Leases topped out at $2.1 million in Q1 2026 and bottomed at $1.5 million in Q1 2022.
• A 5-year average of $1.8 million and a median of $1.8 million in 2024 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2022 — Current Leases jumped 182.88% — and 2025, when it gained 8.05%.
• Anaptysbio's Current Leases stood at $1.6 million in 2022, then advanced by 8.55% to $1.8 million in 2023, then climbed by 8.33% to $1.9 million in 2024, then increased by 8.05% to $2.1 million in 2025, then grew by 1.92% to $2.1 million in 2026.
• Business Quant data shows ANAB's Current Leases at $2.1 million in Q1 2026, $2.1 million in Q4 2025, and $2.0 million in Q3 2025.